Literature DB >> 9928076

Is an intravenous bolus injection required prior to initiating slow intravenous infusion of PACAP38 for prevention of neuronal death induced by global ischemia? The possible presence of a binding protein for PACAP38 in blood.

A Somogyvári-Vigh1, J Svoboda-Teet, S Vigh, A Arimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9928076     DOI： 10.1111/j.1749-6632.1998.tb11243.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  3 in total

1.  The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.

Authors:  Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 2.  Emerging Role of PACAP as a New Potential Therapeutic Target in Major Diabetes Complications.

Authors:  Rubina Marzagalli; Soraya Scuderi; Filippo Drago; James A Waschek; Alessandro Castorina
Journal:  Int J Endocrinol       Date:  2015-05-14       Impact factor: 3.257

Review 3.  Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke.

Authors:  Yuanjian Fang; Reng Ren; Hui Shi; Lei Huang; Cameron Lenahan; Qin Lu; Lihui Tang; Yi Huang; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.